Form 4 Filing for AN2 Therapeutics, Inc.

Patricia A. Martin, a director at AN2 Therapeutics, Inc., acquired 1192 shares of common stock on April 10, 2026, at no cost. These shares were issued in lieu of cash compensation under the issuer's non-employee director compensation policy and vest immediately. Following this transaction, Martin now owns 18097 shares of common stock. The transaction code was 'A' for acquisition, and the ownership is direct.